BUZZ-Valeant Pharmaceutical: Best day in 2016
** Canadian drugmaker's U.S.-listed shares up as much as 14 pct at $29.78; their best day in 2016
** Says board committee completed a review of its accounting practices and had not found any new items that would require additional restatements
** Says on schedule to file its annual report on or before April 29
** Valeant said last week it had asked its lenders for another month to file its annual report, seeking to reduce the risk of a default on its $30 billion debt if it missed the April 29 deadline
** Up to Monday's close, stock had fallen 74 pct this year
© Thomson Reuters 2017 All rights reserved.